Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.

<h4>Background</h4>Data from clinical studies and results from animal models suggest an involvement of the neurotrophin system in the pathology of depression and antidepressant treatment response. Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF)...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Johannes M Hennings, Martin A Kohli, Darina Czamara, Maria Giese, Anne Eckert, Christiane Wolf, Angela Heck, Katharina Domschke, Volker Arolt, Bernhard T Baune, Sonja Horstmann, Tanja Brückl, Torsten Klengel, Andreas Menke, Bertram Müller-Myhsok, Marcus Ising, Manfred Uhr, Susanne Lucae
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d7ff4fab0c1d4b77b1f4b26aa8948ea8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d7ff4fab0c1d4b77b1f4b26aa8948ea8
record_format dspace
spelling oai:doaj.org-article:d7ff4fab0c1d4b77b1f4b26aa8948ea82021-11-18T07:43:07ZPossible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.1932-620310.1371/journal.pone.0064947https://doaj.org/article/d7ff4fab0c1d4b77b1f4b26aa8948ea82013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23750220/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Data from clinical studies and results from animal models suggest an involvement of the neurotrophin system in the pathology of depression and antidepressant treatment response. Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF) and its key receptor Trkb (NTRK2) may therefore influence the response to antidepressant treatment.<h4>Methods</h4>We performed a single and multi-marker association study with antidepressant treatment outcome in 398 depressed Caucasian inpatients participating in the Munich Antidepressant Response Signature (MARS) project. Two Caucasian replication samples (N = 249 and N = 247) were investigated, resulting in a total number of 894 patients. 18 tagging SNPs in the BDNF gene region and 64 tagging SNPs in the NTRK2 gene region were genotyped in the discovery sample; 16 nominally associated SNPs were tested in two replication samples.<h4>Results</h4>In the discovery analysis, 7 BDNF SNPs and 9 NTRK2 SNPs were nominally associated with treatment response. Three NTRK2 SNPs (rs10868223, rs1659412 and rs11140778) also showed associations in at least one replication sample and in the combined sample with the same direction of effects (Pcorr  = .018, Pcorr  = .015 and Pcorr  = .004, respectively). We observed an across-gene BDNF-NTRK2 SNP interaction for rs4923468 and rs1387926. No robust interaction of associated SNPs was found in an analysis of BDNF serum protein levels as a predictor for treatment outcome in a subset of 93 patients.<h4>Conclusions/limitations</h4>Although not all associations in the discovery analysis could be unambiguously replicated, the findings of the present study identified single nucleotide variations in the BDNF and NTRK2 genes that might be involved in antidepressant treatment outcome and that have not been previously reported in this context. These new variants need further validation in future association studies.Johannes M HenningsMartin A KohliDarina CzamaraMaria GieseAnne EckertChristiane WolfAngela HeckKatharina DomschkeVolker AroltBernhard T BauneSonja HorstmannTanja BrücklTorsten KlengelAndreas MenkeBertram Müller-MyhsokMarcus IsingManfred UhrSusanne LucaePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 6, p e64947 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Johannes M Hennings
Martin A Kohli
Darina Czamara
Maria Giese
Anne Eckert
Christiane Wolf
Angela Heck
Katharina Domschke
Volker Arolt
Bernhard T Baune
Sonja Horstmann
Tanja Brückl
Torsten Klengel
Andreas Menke
Bertram Müller-Myhsok
Marcus Ising
Manfred Uhr
Susanne Lucae
Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
description <h4>Background</h4>Data from clinical studies and results from animal models suggest an involvement of the neurotrophin system in the pathology of depression and antidepressant treatment response. Genetic variations within the genes coding for the brain-derived neurotrophic factor (BDNF) and its key receptor Trkb (NTRK2) may therefore influence the response to antidepressant treatment.<h4>Methods</h4>We performed a single and multi-marker association study with antidepressant treatment outcome in 398 depressed Caucasian inpatients participating in the Munich Antidepressant Response Signature (MARS) project. Two Caucasian replication samples (N = 249 and N = 247) were investigated, resulting in a total number of 894 patients. 18 tagging SNPs in the BDNF gene region and 64 tagging SNPs in the NTRK2 gene region were genotyped in the discovery sample; 16 nominally associated SNPs were tested in two replication samples.<h4>Results</h4>In the discovery analysis, 7 BDNF SNPs and 9 NTRK2 SNPs were nominally associated with treatment response. Three NTRK2 SNPs (rs10868223, rs1659412 and rs11140778) also showed associations in at least one replication sample and in the combined sample with the same direction of effects (Pcorr  = .018, Pcorr  = .015 and Pcorr  = .004, respectively). We observed an across-gene BDNF-NTRK2 SNP interaction for rs4923468 and rs1387926. No robust interaction of associated SNPs was found in an analysis of BDNF serum protein levels as a predictor for treatment outcome in a subset of 93 patients.<h4>Conclusions/limitations</h4>Although not all associations in the discovery analysis could be unambiguously replicated, the findings of the present study identified single nucleotide variations in the BDNF and NTRK2 genes that might be involved in antidepressant treatment outcome and that have not been previously reported in this context. These new variants need further validation in future association studies.
format article
author Johannes M Hennings
Martin A Kohli
Darina Czamara
Maria Giese
Anne Eckert
Christiane Wolf
Angela Heck
Katharina Domschke
Volker Arolt
Bernhard T Baune
Sonja Horstmann
Tanja Brückl
Torsten Klengel
Andreas Menke
Bertram Müller-Myhsok
Marcus Ising
Manfred Uhr
Susanne Lucae
author_facet Johannes M Hennings
Martin A Kohli
Darina Czamara
Maria Giese
Anne Eckert
Christiane Wolf
Angela Heck
Katharina Domschke
Volker Arolt
Bernhard T Baune
Sonja Horstmann
Tanja Brückl
Torsten Klengel
Andreas Menke
Bertram Müller-Myhsok
Marcus Ising
Manfred Uhr
Susanne Lucae
author_sort Johannes M Hennings
title Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
title_short Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
title_full Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
title_fullStr Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
title_full_unstemmed Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
title_sort possible associations of ntrk2 polymorphisms with antidepressant treatment outcome: findings from an extended tag snp approach.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/d7ff4fab0c1d4b77b1f4b26aa8948ea8
work_keys_str_mv AT johannesmhennings possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT martinakohli possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT darinaczamara possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT mariagiese possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT anneeckert possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT christianewolf possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT angelaheck possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT katharinadomschke possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT volkerarolt possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT bernhardtbaune possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT sonjahorstmann possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT tanjabruckl possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT torstenklengel possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT andreasmenke possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT bertrammullermyhsok possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT marcusising possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT manfreduhr possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
AT susannelucae possibleassociationsofntrk2polymorphismswithantidepressanttreatmentoutcomefindingsfromanextendedtagsnpapproach
_version_ 1718423066835419136